Navigation Links
The Queen Of All Contraceptives Released

A few months back, the Food and Drug Administration approved a new birth control pill, Lybrel. It is as effective at preventing pregnancy as the other pills already in the market , but overrides them with one advantage: Women who take it will never get their periods.

Lybrel is landing on pharmacy shelves this month. Now menstruation may never be the same- it may disappear altogether.

Already the first few volleys in this battle have been exchanged, a barrage of advertising and research highlighting the debilitating effects of periods and the joys of menstrual suppression.

Women libbers may argue- periods and their mood swings are bad for family values (cranky mothers), bad for womens health, bad for the fashion industry and bad for the economy (leave taken on grounds of period pain).

In a presentation by Lybrels maker, Wyeth, to investors and analysts last October, Dr. Ginger D. Constantine, the companys therapeutic director for womens health, laid the groundwork. Citing company-backed studies, she reported that menstruating women feel less effective at work and take more sick days. Not only that, but they dont exercise and they wear dark clothes more often, she said.

Suddenly, news articles are weighing the pros and cons of the monthly cycles. Yet, history shows that such debates are, well, cyclical. In the 1870s and 1880s, when Americans were debating the value of higher education for women, a flurry of research asserted that womens cycling constitutions made them unfit for sustained mental and physical labor.

Henry Maudsley, a British doctor, reflected popular opinion when he observed that menstruation doomed girls to failure in college. Comparing boys and girls, Maudsley insisted in an article, was not a question of two bodies and minds that are in equal physical condition, but of one body and mind capable of sustained and regular hard labor, and of another body and mind which one quarter of each month, during the best years of life, is more or less sick and unfit for hard work.

After women pressed ahead, attended college and excelled in the halls of learning, the debate about menstrual cycles shifted from their suitability for higher education to their suitability for public life in general. When the suffragists asked to participate in the political process, experts retaliated with more research proving that women belonged in the domestic sphere; menstruation figured prominently among the reasons.

Once women won the right to vote in 1920, the menstruation-equals-inadequacy debate waned for a while. In fact, two decades later, new proof arrived that women were perfectly fit and capable (even when bleeding) and therefore should step right up and join the war effort. But after the war, a fresh batch of studies were released proving that children need their moms at home, that the workplace is potentially hazardous to womens unborn children and that womens cycles make them less efficient workers than men.

In any case, the present debate against such a pill is not a particularly profitable attitude for Wyeth, as it angles for its share of the $1.7 billion annual American market for birth control pills.

So as business-savvy officials re-conceptualize menstruation as a disease in need of treatment, bleeding women may well be in for a lot of confusion- to stop or not to?


'"/>




Related medicine news :

1. Beauty Queens Urge On The Importance Of Maintaining Bone Integrity
2. Queensland Bans OTC Sales Of Cold And Flu Drugs
3. Queensland Opposition not happy over hiring consultancy
4. The mystery of the bulge in North Queenslanders
5. Queensland : Call for improved mental health services
6. Surgery cancellations in Queens land Hospital
7. Mammograms in Queensland Reviewed
8. Queensland Government to Meet its Medical Targets
9. Meningococcal Scare in Queensland
10. Medical Person As Health Minister To Improve Queenslands Health System
11. Dentist Tested Positive For HIV - Queensland Health To Screen Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... 19, 2017 , ... Bone Solutions Inc. (BSI), an orthobiologics ... medical device, OsteoCrete®. OsteoCrete® bone void filler is designed to assist with bone ... a critical property for bone health and development. , “We’re excited to bring ...
(Date:9/19/2017)... ... September 19, 2017 , ... Premiere Long Island dental office Gold ... named one of the best dentists in America under age 40 by Incisal Edge ... Every fall, the magazine features the best 40 dentists under the age of 40 ...
(Date:9/19/2017)... ... 19, 2017 , ... Inc. magazine ranked Endo-Systems ... the nation's fastest-growing private companies. The list represents a unique look at the ... and midsized businesses. Endo-Systems is a leading B2B distributor of today’s most scientifically ...
(Date:9/18/2017)... , ... September 18, 2017 , ... TransLuma is a set of dissolving transitions created ... dissolve in or dissolve away the luminance of a scene without the use of keyframes. ... next scene before fully transitioning over. , TransLuma allows editors to gradually dissolve away the ...
(Date:9/18/2017)... CA (PRWEB) , ... September 18, 2017 , ... Cosmetic ... on its website. According to the senior editor of Cosmetic Tow, “Our forum section ... as well as provide answers to other forum members thinking about having cosmetic surgery. ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017  Consumer reviews on the independent ... as the number one company for hearing aids, ranking it ... fifteen other brands. ... Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high performance, ...
(Date:9/9/2017)... WASHINGTON , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, ... to Washington, D.C. offering free MRI brain scans to the public.Where:  ... – will be parked at 501 K Street NW, Washington, D.C.What:BTF brings ...
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
Breaking Medicine Technology: